Blossom Genetics Corporation Ltd
 | |
| ISIN | 🆔 |
|---|---|
| Industry | Genetics |
| Founded 📆 | 2019 |
| Founder 👔 | Oskar Fletcher, Oliver Davies, Naeem Dungarwalla |
| Headquarters 🏙️ | , , |
Area served 🗺️ | |
| Members | |
Number of employees | |
| 🌐 Website | www |
| 📇 Address | |
| 📞 telephone | |
Blossom Genetics Corporation Ltd is a United Kingdom-based cannabis genetics company, headquartered in London. Blossom Genetics has one licensed production facility, sales licences, and operations in 2 countries.[1]
History[edit]
Blossom was founded in 2019 by Oskar Fletcher, Oliver Davies and Naeem Dungarwalla. Blossom Genetics is a patient focused global organisation that produces and distributes proprietary medicinal cannabis genetics and products.
Global Operations and Exports[edit]
Blossom owns and operates global subsidiaries to serve the medical cannabis market in jurisdictions where it is legal and regulated:
Blossom Genetics Portugal. - located in Lisbon, Portugal
Blossom Genetics China - Located in Shanghai, China
Strategic Partnerships & Acquisitions[edit]
In 2019, Blossom announced it had entered into global partnership with The James Hutton Institute, a scientific research institute in Scotland, to focus on developing cannabis genetics for the global medical market.
Genetic Research[edit]
Blossom's genetic research allows them to produce bespoke strains with specific agronomic and pharmaceutical traits demanded by the market. Through modern genetic techniques they developed the tools necessary for the cost effective production of cannabis genotypes that meet the need of growers through improved agronomic performance focusing on traits such as disease resistance, time from seed to harvest, yield and vigour.
References[edit]
This article "Blossom Genetics" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Blossom Genetics. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
